SERUM LEVELS OF NEUROLEPTICS MEASURED BY DOPAMINE RADIORECEPTOR ASSAY AND SOME CLINICAL OBSERVATIONS

被引：65

作者：

CALIL, HM

AVERY, DH

HOLLISTER, LE

CREESE, I

SNYDER, SH

机构：

来源：

PSYCHIATRY RESEARCH | 1979年 / 1卷 / 01期

关键词：

dopamine radioreceptor assay; Neuroleptic serum levels;

D O I：

10.1016/0165-1781(79)90026-X

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

A new dopamine radioreceptor assay was used to measure serum concentrations of neuroleptics during treatment of 58 patients. Results of this assay are expressed as chlorpromazine equivalents. Serum concentrations varied with different drugs, with extremely high levels in patients receiving thioridazine or mesoridazine. No detectable serum levels were found in 11 patients, probably either due to low drug doses or noncompliance in taking medication. Best results with the assay were obtained in the 22 patients treated with haloperidol. Serum concentrations of haloperidol were correlated with dose and were related to the Brief Psychiatric Rating Scale (BPRS) total pathology score, as well as to BPRS factor scores for thinking disturbance and paranoid disturbance. Serum concentrations of haloperidol were not different among patients with or without the presence of extrapyramidal symptoms or among patients receiving or not receiving concurrent antiparkinson medication. © 1979.

引用

页码：39 / 44

页数：6

共 19 条

[1]

American Psychiatric Association, DSM-II: Diagnostic and Statistical Manual of Mental Disorders, (1968)

[2]

Clark, Kaul, Whitfield, Et al., Chlorpromazine kinetics and clinical response, Psychopharmacology Bulletin, 14, (1978)

[3]

Creese, Snyder, A simple and sensitive radioreceptor assay for antischizophrenic drugs in blod, Nature, 270, (1977)

[4]

Curry, Marshall, Davis, Janowsky, Chlorpromazine plasma levels and effects, Archives of General Psychiatry, 22, (1970)

[5]

Davis, Erickson, Dekirmenjian, Plasma levels of anti-psychotic drugs and clinical response, Psychopharmacology: A Generation of Progress, (1978)

[6]

Garver, Dekirmenjian, Davis, Casper, Erickson, Neuroleptic drug levels and therapeutic response: Preliminary observations with red blood cell bound butaperazine, American Journal of Psychiatry, 134, (1977)

[7]

Loga, Curry, Lader, Interactions of orphenadrine and phenobarbitone with chlorpromazine: Plasma concentrations and effects in man, British Journal of Clinical Pharmacology, 2, (1975)

[8]

MacKay, Healy, Baker, The relationship of plasma chlorpromazine to its 7-hydroxy and sulphoxide metabolites in a large population of chronic schizophrenics, British Journal of Clinical Pharmacology, 1, (1974)

[9]

May, Van Putten, Plasma levels of chlorpromazine in schizophrenia, Archives of General Psychiatry, 35, (1978)

[10]

Phillipson, McKeown, Baker, Healy, Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis, British Journal of Psychiatry, 131, (1977)

← 1 2 →